Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adhesion Study of Rotigotine Patches in Parkinson's Disease
NCT04183634Phase 1Terminated
- Sponsor
- Sandoz
- Start
- Dec 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rotigotine in Parkinson's disease (PD) (2 arms), sponsored by Sandoz. Primary endpoint: Patch Adhesion at 24 hours. Started Dec 2019; status: terminated.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04183634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04183634.